Sekisui Medical Technology (Suzhou) Co., Ltd. held its opening ceremony in Suzhou Industrial Park on August 8. Engaged in R&D, production, and sales of diagnostic reagents for blood and diabetic diseases, the company covers a land area of 4,500 square meters with 5 million US dollars registered capital. Its estimated annual output is 1.8 million bottles.

As the second wholly-owned subsidiary of Sekisui Chemical Co., Ltd. in China, Sekisui Medical Technology (Suzhou) Co., Ltd. was officially incorporated on December 21, 2015. After commencement of production, the company will chiefly focus on the Asian market and speed up the process of localization of the parent company's internal divisions in China, and plan to provide the most advanced high-quality diagnostic reagents and related products to the users the world over.